PARLIAMENT QUESTION: RESEARCH, DEVELOPMENT AND INNOVATION SCHEME

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic - Aims to crowd-in private R&D which currently contributes only ~36% of India's GERD (vs >65% in OECD economies) [S1]. - Concessional capital reduces the valley of death between lab-prototype and commercial product [S1].

Scientific / Technological - Focus on sunrise tech (AI, quantum, biotech) aligns with National Quantum Mission, IndiaAI Mission, BioE3 Policy [S1]. - BIRAC's ₹2,000 crore biotech call is the first sectoral deployment [S5].

Administrative / Governance - Multi-layered approval (PM-led GB → EGoS → EC) ensures inter-ministerial coordination but raises bureaucratic-delay risk [S2]. - Fund-of-Funds model mirrors SIDBI's FFS for startups — leverages domain expertise of SLFMs [S2].

Legal / Statutory - Anchored in ANRF Act, 2023; governed by ANRF (Utilization of RDI Fund) Financial Rules, 2026 [S3]. - Distinct from earlier SERB grants — RDI is repayable/refinanced capital, not pure grant [S1].

6. Recent Developments

7. Prelims Hooks

8. Mains Relevance

Plausible question stems: 1. "The RDI Scheme marks a paradigm shift from grant-based to refinance-based public funding of innovation. Discuss its design and challenges." (15M) 2. "Examine how ANRF's two-tier funding architecture seeks to bridge India's private R&D gap." (10M) 3. "Despite a ₹1 lakh crore commitment, the success of the RDI Scheme will hinge on the institutional capacity of Second-Level Fund Managers. Critically analyse." (15M)

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources